Mark J. Shlomchik
- Immunology top 0.01%
- Rheumatology top 0.05%
- Radiology, Nuclear Medicine and Imaging top 0.1%
- Molecular Biology top 1%
- Hematology top 0.2%
- Co-authors
- Ann Marshak‐RothsteinFlorian WeiselSean R. ChristensenMichael KashgarianAnn M. HabermanMartin WeigertWarren D. ShlomchikOwen Chan
- Topics
- T-cell and B-cell Immunology (179 papers)Immune Cell Function and Interaction (120 papers)Immunotherapy and Immune Responses (95 papers)
- Cited by
- ImmunologyRheumatologyHematology
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Mark J. Shlomchik
280 papers receiving 25.8k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Immunology 20.7k
- Rheumatology 4.4k
- Radiology, Nuclear Medicine and Imaging 4.2k
- Molecular Biology 4.0k
- Hematology 2.3k
Countries citing papers authored by Mark J. Shlomchik
This map shows the geographic impact of Mark J. Shlomchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Shlomchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Shlomchik more than expected).
Fields of papers citing papers by Mark J. Shlomchik
This network shows the impact of papers produced by Mark J. Shlomchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Shlomchik. The network helps show where Mark J. Shlomchik may publish in the future.
Co-authorship network of co-authors of Mark J. Shlomchik
This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Shlomchik. A scholar is included among the top collaborators of Mark J. Shlomchik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Shlomchik. Mark J. Shlomchik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 4 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 19 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 60 | |
| 9 | 42 | |
| 10 | 2 | |
| 11 | 8 | |
| 12 | 104 | |
| 13 | 318 | |
| 14 | 55 | |
| 15 | 209 | |
| 16 | 102 | |
| 17 | 39 | |
| 18 | 41 | |
| 19 | 423 | |
| 20 | 39 |
About Mark J. Shlomchik
Mark J. Shlomchik is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Rheumatology, having authored 288 papers that have together received 26.2k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (179 papers), Immune Cell Function and Interaction (120 papers) and Immunotherapy and Immune Responses (95 papers). The work is most often cited by research in Immunology (20.7k citations), Rheumatology (4.4k citations) and Hematology (2.3k citations). Mark J. Shlomchik has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Ann Marshak‐Rothstein, Florian Weisel, Sean R. Christensen, Michael Kashgarian, Ann M. Haberman, Martin Weigert, Warren D. Shlomchik, Owen Chan, Ian R. Rifkin and Lynn G. Hannum. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.